BNB treasury company faces delisting from Nasdaq on Aug. 21

Windtree Therapeutics, a struggling biotech firm that rebranded itself around holding BNB reserves, is set to be delisted from the Nasdaq after its stock collapsed below the exchange’s minimum price requirement. According to a filing with the Securities and Exchange Commission, Nasdaq will remove Windtree from its listings on Aug. 21 after the company failed […]